Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Humana Inc.

Humm Group Limited ( ($AU:HUM) ) has shared an announcement. The Takeovers Panel has outlined concerns over Humm Group Limited’s compliance with an...

Humm Group Rebuked by Takeovers Panel Over Governance Undertaking

Humana ( ($HUM) ) has provided an announcement. At Humana Inc.’s regular annual meeting of stockholders held on April 16, 2026, shareholders electe...

Humana Shareholders Approve Directors, Auditor and Incentive Plan

Humm Group Limited ( ($AU:HUM) ) has issued an update. Humm Group Limited has issued a supplementary disclosure to the existing notice for its Extr...

Humm Group Issues Supplementary Disclosure and New Proxy Details Ahead of Resumed EGM

Humm Group Limited ( ($AU:HUM) ) has provided an update. Humm Group has issued supplementary disclosure ahead of its adjourned general meeting, con...

Humm Group Moves to Strengthen Board, Urges Shareholders to Reject Director-Removal Resolution

The latest announcement is out from Hua Medicine ( ($HK:2552) ). Hua Medicine plans to update its constitutional documents by replacing its third a...

Hua Medicine Seeks Shareholder Approval for Digital-Friendly Articles Update

Humm Group Limited ( ($AU:HUM) ) just unveiled an update. The Takeovers Panel has received an application from major Humm Group shareholder Andrew ...

Review Panel Stays Takeovers Panel Orders in Humm Group Case

Owning the entire market is viewed as a safe investing strategy. 


XLV, VHT, IXJ: Invest in the Healthcare Sector with Exchange-Traded Funds

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Humana (HUM) and Adagio Medical Holdings (ADGM) with...

Analysts Are Bullish on These Healthcare Stocks: Humana (HUM), Adagio Medical Holdings (ADGM)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Relay Therapeutics (RLAY) and Humacyte (HUMA) with b...

Wall Street Analysts Are Bullish on Top Healthcare Picks

The healthcare sector got a boost after Centers for Medicare & Medicaid Services (CMS) finalized 2027 reimbursement rates. Medicare will raise paym...

UnitedHealth (UNH) vs. Humana (HUM): Which Healthcare Stock Is the Better Bet After the CMS Update?

UnitedHealth (NYSE:UNH) shares are climbing nearly 7% in after-hours trading, while Humana (NYSE:HUM) is rallying close to 12%, as investors react ...

UnitedHealth (UNH) or Humana (HUM): Which Stock Is the Better Buy After CMS’ Surprise Rate Hike

Medicare payments are a big source of revenue for health insurers. 


HUM, UNH, CVS: Healthcare Stocks Soar on 2.48% Medicare Rate Increase

Bernstein analyst Courtney Breen maintained a Buy rating on Humana yesterday and set a price target of $211.00. According to TipRanks, Breen is a 4...

Bernstein Sticks to Its Buy Rating for Humana (HUM)

Humana AB ( ($SE:HUM) ) has shared an update. Humana AB has called its annual general meeting for May 7, 2026, in Stockholm, setting out how shareh...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HUM	$215.23	+0.13%	1.01M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HUM	$215.23	+0.1%	1.01M
3
4
5
6

HUM

HUM

Get Humana Inc. Data in Excel

Get Humana Inc. Data in Excel